44 related articles for article (PubMed ID: 15464700)
1. Hypertrophic obstructive cardiomyopathy: alternative therapeutic options.
Lakkis N; Kleiman N; Killip D; Spencer WH
Clin Cardiol; 1997 May; 20(5):417-8. PubMed ID: 9134270
[No Abstract] [Full Text] [Related]
2. Percutaneous Septal Reduction Therapy in a Patient with Severely Symptomatic Hypertrophic Obstructive Cardiomyopathy: An experience from a tertiary care centre.
Al Lawati H; Nadar SK; Al Riyami AB
Sultan Qaboos Univ Med J; 2022 Nov; 22(4):443-447. PubMed ID: 36407690
[No Abstract] [Full Text] [Related]
3. Utility of antitachycardia pacing in hypertrophic cardiomyopathy.
MacNamara JP; Link MS
Heart Rhythm; 2023 Oct; 20(10):1393-1394. PubMed ID: 37479073
[No Abstract] [Full Text] [Related]
4. Effect of Personalized Accelerated Pacing in Patients With Nonobstructive Hypertrophic Cardiomyopathy.
Riaz S; McMahon SR; Stockey K; Meyer M; Weissler-Snir A
J Am Coll Cardiol; 2024 Apr; 83(15):1492-1493. PubMed ID: 38599721
[No Abstract] [Full Text] [Related]
5. Finding an Unobstructed View Toward the Treatment of Nonobstructive Hypertrophic Cardiomyopathy: Lifting the Hunger Fog.
Ambardekar AV; Kopecky BJ; Raymer DS
J Am Coll Cardiol; 2024 May; 83(21):2049-2051. PubMed ID: 38777508
[No Abstract] [Full Text] [Related]
6. Malnutrition complicating clinical presentation of obstructive hypertrophic cardiomyopathy.
Karadzha A; Schaff HV
JTCVS Tech; 2023 Dec; 22():225-227. PubMed ID: 38152214
[No Abstract] [Full Text] [Related]
7. Percutaneous septal ablation in hypertrophic obstructive cardiomyopathy.
Faber L
Eur J Med Res; 2006 Oct; 11(10):423-31. PubMed ID: 17107876
[TBL] [Abstract][Full Text] [Related]
8. Management of complete heart block following percutaneous transluminal septal myocardial ablation for patients with hypertrophic cardiomyopathy.
Cheng TO
Int J Cardiol; 2009 Jan; 131(3):420. PubMed ID: 18023896
[No Abstract] [Full Text] [Related]
9. [Balloon rupture and alcohol leakage into the left anterior descending coronary artery during percutaneous septal ablation for hypertrophic obstructive cardiomyopathy].
Antolinos Pérez MJ; de la Morena Valenzuela G; Gimeno Blanes JR; Cerdán Sánchez Mdel C; Hurtado Martínez JA; Valdés Chavarri M
Rev Esp Cardiol; 2005 Jul; 58(7):872-4. PubMed ID: 16022820
[TBL] [Abstract][Full Text] [Related]
10. [Aspects of treatment of hypertrophic obstructive cardiomyopathy with emphasis on the role of percutaneous transluminal ablation of the myocardial septum].
Veselka J
Vnitr Lek; 2001 Dec; 47(12):887-91. PubMed ID: 11826555
[TBL] [Abstract][Full Text] [Related]
11. Percutaneous transluminal septal myocardial ablation: a novel, nonsurgical treatment for symptomatic hypertrophic cardiomyopathy.
Kar S; Makkar R
Rev Cardiovasc Med; 2001; 2(2):97-102. PubMed ID: 12439386
[TBL] [Abstract][Full Text] [Related]
12. Permanent pacing for complete atrioventricular block after nonsurgical (alcohol) septal reduction in patients with obstructive hypertrophic cardiomyopathy.
Reinhard W; Ten Cate FJ; Scholten M; De Laat LE; Vos J
Am J Cardiol; 2004 Apr; 93(8):1064-6. PubMed ID: 15081461
[TBL] [Abstract][Full Text] [Related]
13. Conservative management of complete heart block complicating percutaneous transluminal septal myocardial ablation for patients with obstructive hypertrophic cardiomyopathy.
Cheng TO
Am J Cardiol; 2004 Oct; 94(7):982. PubMed ID: 15464700
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
